<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03117283</url>
  </required_header>
  <id_info>
    <org_study_id>GDPHCM-GI-02</org_study_id>
    <nct_id>NCT03117283</nct_id>
  </id_info>
  <brief_title>Laparoscopic Total Gastrectomy With Versus Without Bursectomy</brief_title>
  <official_title>Laparoscopic Total Gastrectomy With Bursectomy in a Left Outside Bursa Omentalis Approach Versus Laparoscopic Total Gastrectomy Without Bursectomy for Advanced Posterior Gastric Wall Cancer: a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong Provincial Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial Hospital of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bursectomy is widely performed in open surgery for advanced gastric cancer in East Asia.
      However laparoscopic D2 radical total gastrectomy with complete bursectomy is difficult and
      rare performed. Herein, we conduct a single-centre randomized controlled trial to explore the
      safety and feasibility of totally laparoscopic D2 radical total gastrectomy using a left
      outside bursa omentalis approach for achieving complete bursectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although, the clinical value of bursectomy in addition to D2 lymphadenectomy in radical
      gastrectomy for curable gastric cancer is controversial. Data analysis of the nationwide
      registry of gastric cancer in Japanese revealed that 10.7% of patients with subserosal and
      serosal positive cancer developed peritoneal recurrence after radical gastrectomy. Some
      trials, although, indicated a biologically reasonable but statistically non-significant
      advantage to bursectomy. But for patients with posterior gastric wall trans-serosal disease,
      such micrometastases can constitute the seeds of later recurrence. The non-bursectomy showed
      worse overall survival. Early removal of micrometastases and cancer cells deposited might
      prove beneficial and a possible therapeutic effect. In any case, the authors reasonably
      concluded that bursectomy should not be abandoned at this time. The hypothesis that it might
      actually enhance survival should be entertained. In the past decades, Japanese, Korea,
      Chinese and even Turkey, surgeons have continued to performed bursectomy and lymph nodes
      dissection as the conventional open procedures for advanced gastric cancer. Lymph nodes
      dissection and bursectomy is routinely regarded as a standard surgical procedure during
      radical open gastrectomy for tumors penetrating the serosa of the posterior gastric wall.
      Complete bursectomy and lymphadenectomy in open radical gastrectomy may represents a
      formidable challenge to the best of surgeons and its influences on operative morbidity and
      mortality, but it can be also safely performed in high volume experience centers or by
      experienced surgeons with mortality rate of &lt;1% and morbidity rates around 14%.

      Generally speaking, bursectomy is incomplete without total gastrectomy. The concept of
      bursectomy mentioned above is always almost confined to removal of the local anterior
      membrane of the transverse mesocolon and pancreatic capsule and to open radical gastrectomy.
      With the generalization and development of laparoscopic technology, laparoscopic surgery for
      advanced gastric cancer as clinical study has extensively performed in Asia.The investigators
      take the lead in carrying out laparoscopic bursectomy and D2 radical gastrectomy by. Herein,
      the investigators conduct a single-centre randomized controlled trial to explore the safety
      and feasibility of totally laparoscopic D2 radical total gastrectomy using a left outside
      bursa omentalis approach for achieving complete bursectomy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 28, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>The early morbidity is defined as the adverse event observed during peri-operative time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Intraoperative</time_frame>
    <description>The mean operative time of the procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymph node</measure>
    <time_frame>14 days</time_frame>
    <description>This outcome consists of the number of total lymph nodes harvested and the number of lymph nodes in the wall of bursa omentalis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First ambulation</measure>
    <time_frame>30 days</time_frame>
    <description>The time to first ambulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year survival</measure>
    <time_frame>3 years</time_frame>
    <description>3-year disease free survival rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-year survival</measure>
    <time_frame>5 years</time_frame>
    <description>5-year overall survival rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Intraoperative</time_frame>
    <description>The mean estimated blood loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First flatus</measure>
    <time_frame>30 days</time_frame>
    <description>The time to first flatus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First liquid diet</measure>
    <time_frame>30 days</time_frame>
    <description>The time to liquid diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Postoperative hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Laparoscopic Gastrectomy</condition>
  <condition>Laparoscopic Bursectomy</condition>
  <condition>A Left Outside Bursa Omentalis Approach</condition>
  <arm_group>
    <arm_group_label>LTG with Bursectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>laparoscopic D2 radical total gastrectomy with bursectomy using a left outside bursa omentalis approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTG without Bursectomy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>laparoscopic D2 radical total gastrectomy without bursectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic D2 radical total gastrectomy with bursectomy using a left outside bursa omentalis approach</intervention_name>
    <description>Patients with advanced posterior gastric wall cancer including in the laparoscopic total gastrectomy (LTG) with bursectomy group will undergo laparoscopic D2 radical total gastrectomy with bursectomy using a left outside bursa omentalis approach.</description>
    <arm_group_label>LTG with Bursectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic D2 radical total gastrectomy without bursectomy</intervention_name>
    <description>Patients who are included in the laparoscopic total gastrectomy (LTG) without bursectomy group will undergo laparoscopic D2 radical total gastrectomy without bursectomy in a conventional manner.</description>
    <arm_group_label>LTG without Bursectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary gastric adenocarcinoma diagnosed pathologically by endoscopic biopsy

          -  Tumor located in the posterior wall of upper and middle third stomach estimated by
             endoscopy and CT scan

          -  Informed consent

          -  Eastern Cooperative Oncology Group (ECOG): 0 ot 1

          -  American Society of Anesthesiologists （ASA） score: Ⅰto Ⅲ

        Exclusion Criteria:

          -  Pregnancy or female in suckling period

          -  Contraindication to general anesthesia (severe cardiac and/or pulmonary disease)

          -  Severe mental disease

          -  Emergency operation due to complication (bleeding, perforation or obstruction) caused
             by primary tumor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wenjun Xiong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei Wang, M.D., PH.D.</last_name>
    <phone>+86-13922255515</phone>
    <email>wangwei16400@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangdong Province Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Wang, M.D.,PH.D.</last_name>
      <phone>+86-13922255515</phone>
      <email>wangwei16400@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Wenjun Xiong, M.D.</last_name>
      <phone>+86-15920553177</phone>
      <email>xiongwj1988@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Wei Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jin Wan</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wenjun Xiong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Hundahl SA. The potential value of bursectomy in operations for trans-serosal gastric adenocarcinoma. Gastric Cancer. 2012 Jan;15(1):3-4. doi: 10.1007/s10120-011-0121-6.</citation>
    <PMID>22160297</PMID>
  </results_reference>
  <results_reference>
    <citation>Japanese Gastric Cancer Association Registration Committee, Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, Arai K, Kodera Y, Nashimoto A. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9(2):51-66.</citation>
    <PMID>16767357</PMID>
  </results_reference>
  <results_reference>
    <citation>Fujita J, Kurokawa Y, Sugimoto T, Miyashiro I, Iijima S, Kimura Y, Takiguchi S, Fujiwara Y, Mori M, Doki Y. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer. 2012 Jan;15(1):42-8. doi: 10.1007/s10120-011-0058-9. Epub 2011 May 15.</citation>
    <PMID>21573917</PMID>
  </results_reference>
  <results_reference>
    <citation>Imamura H, Kurokawa Y, Kawada J, Tsujinaka T, Takiguchi S, Fujiwara Y, Mori M, Doki Y. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg. 2011 Mar;35(3):625-30. doi: 10.1007/s00268-010-0914-5.</citation>
    <PMID>21161652</PMID>
  </results_reference>
  <results_reference>
    <citation>Kayaalp C, Piskin T, Olmez A. Complications of bursectomy after radical gastrectomy for gastric cancer. World J Surg. 2012 Jan;36(1):229; author reply 230. doi: 10.1007/s00268-011-1218-0.</citation>
    <PMID>21833663</PMID>
  </results_reference>
  <results_reference>
    <citation>Hirao M, Kurokawa Y, Fujita J, Imamura H, Fujiwara Y, Kimura Y, Takiguchi S, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: Final analysis of a multicenter randomized controlled trial. Surgery. 2015 Jun;157(6):1099-105. doi: 10.1016/j.surg.2014.12.024. Epub 2015 Feb 20.</citation>
    <PMID>25704429</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang W, Xiong W, Liu Z, Luo L, Zheng Y, Tan P, Diao D, Zou L, Wan J. Clinical significance of No. 10 and 11 lymph nodes posterior to the splenic vessel in D2 radical total gastrectomy: An observational study. Medicine (Baltimore). 2016 Aug;95(32):e4581. doi: 10.1097/MD.0000000000004581.</citation>
    <PMID>27512888</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang W, Liu Z, Xiong W, Zheng Y, Luo L, Diao D, Wan J. Totally laparoscopic spleen-preserving splenic hilum lymph nodes dissection in radical total gastrectomy: an omnibearing method. Surg Endosc. 2016 May;30(5):2030-5. doi: 10.1007/s00464-015-4438-9. Epub 2015 Jul 23.</citation>
    <PMID>26201417</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <last_update_submitted>April 12, 2017</last_update_submitted>
  <last_update_submitted_qc>April 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Wei Wang</investigator_full_name>
    <investigator_title>Wei Wang M.D., PhD.</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Radical total gastrectomy</keyword>
  <keyword>Bursectomy</keyword>
  <keyword>Advanced posterior gastric wall cancer</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data has not been published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

